Clinical Trials on Necrotizing Scleritis in Netherlands

Total 205 results

Maastricht University Medical Center

Unknown

Intestinal Failure in Necrotising Enterocolitis

Necrotizing Enterocolitis

Netherlands
Ra Pharmaceuticals

Terminated

Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy

Immune Mediated Necrotizing Myopathy

United States, Netherlands, France, United Kingdom
Interscope, Inc.

Completed

EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial

Acute Pancreatitis | Necrotizing Pancreatitis | Acute Pancreatic Necrosis

United States, Netherlands, Germany
Amsterdam UMC, location VUmc

Recruiting

Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS). (DOT-MS)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Princess Beatrix Muscle Foundation

Recruiting

Add-on Intravenous Immunoglobulins in Early Myositis (TIMEISMUSCLE)

Myositis | Dermatomyositis | Polymyositis | Antisynthetase Syndrome | Immune-Mediated Necrotizing Myopathy | Inflammatory Myopathy, Idiopathic

Netherlands
Merck KGaA, Darmstadt, Germany
Merck Serono S.A., Geneva

Completed

An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™. (SMART)

Multiple Sclerosis, Relapsing-Remitting

Netherlands
Amphia Hospital
Sanofi; TEVA Pharmachemie

Unknown

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) (OCTIMS)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
Stichting Treatmeds

Recruiting

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS (Noisy Rebels)

Nervous System Diseases | Multiple Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Multiple Sclerosis, Relapsing-Remitting

Netherlands
UMC Utrecht
Princess Beatrix Muscle Foundation

Completed

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Netherlands
UMC Utrecht
Radboud University Medical Center; University Medical Center Groningen; Royal... and other collaborators

Recruiting

Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)

Systemic Sclerosis

Netherlands
Amsterdam UMC, location VUmc

Recruiting

B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis (BLOOMS)

Multiple Sclerosis, Relapsing-Remitting

Netherlands
University Medical Center Groningen
University of Groningen

Recruiting

The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis (MS-CEBA)

Multiple Sclerosis

Netherlands
Maastricht University Medical Center
Orbis Medical Centre

Completed

Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Multiple Sclerosis Self Monitoring Study (MSSM)

Multiple Sclerosis

Netherlands
Radboud University Medical Center

Terminated

The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Netherlands
Zuyderland Medisch Centrum
Scannexus

Active, not recruiting

Ultra-high-field Brain MRI in Multiple Sclerosis (ULTIMS)

Multiple Sclerosis

Netherlands
Newron Sweden AB

Terminated

A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Newron Sweden AB

Terminated

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
UMC Utrecht
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis (MANUS)

Systemic Sclerosis | Digital Ulcer

Netherlands
Zoé van Kempen

Completed

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients (COMS-19)

Multiple Sclerosis

Netherlands
Verge Genomics

Recruiting

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Canada, Netherlands
Khondrion BV
Julius Clinical; ProPharma Group; Europees Fonds voor Regionale Ontwikkeling... and other collaborators

Active, not recruiting

The KHENERGYC Study

Mitochondrial Diseases | MELAS | Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation | Subacute Necrotizing Encephalomyelopathy

Netherlands
Amsterdam UMC, location VUmc

Completed

The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis (WOC)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
National MS Foundation, The Netherlands; Voeding Leeft

Recruiting

Lifestyle Intervention for Patients With Multiple Sclerosis (LIMS)

Multiple Sclerosis

Netherlands
Academic MS Center Limburg

Terminated

Vitamin D3 and the Stress-axis in MS

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
Genzyme, a Sanofi Company; Universiteit Leiden; Personal Fitness Nederland; MS... and other collaborators

Recruiting

Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis (DBL)

Multiple Sclerosis

Netherlands
University Medical Center Groningen

Recruiting

Optimizing INITIation of Non-invasive Ventilation in ALS Patients (INITIALS)

Amyotrophic Lateral Sclerosis

Netherlands
Amsterdam UMC, location VUmc
Erasmus Medical Center; St. Antonius Hospital; Rijnstate Hospital; OLVG; Prothya...

Completed

Towards Personalized Dosing of Natalizumab in Multiple Sclerosis (PDNMS)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis (RESTORE)

Multiple Sclerosis | Internuclear Ophthalmoplegia

Netherlands
BBB-Therapeutics B.V.

Terminated

Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

Multiple Sclerosis | Healthy Volunteers

Netherlands
Radboud University Medical Center

Unknown

The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )

Systemic Sclerosis | Raynaud Phenomena

Netherlands
The University of Queensland
King's College London; UMC Utrecht; Julius Clinical; FightMND

Completed

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS) (MetFlex)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Netherlands, United Kingdom, Australia
Retrotope, Inc.

Recruiting

RT001 in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Netherlands, Estonia, Latvia, Sweden
Erasmus Medical Center
Utrecht University

Unknown

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex (RAPIT)

Tuberous Sclerosis Complex | TSC Related Cognitive Disability | TSC Related Autism | TSC Related Learning Problems

Netherlands
Biogen

Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Relapsing-remitting Multiple Sclerosis

Belgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
Erasmus Medical Center

Unknown

The Cognitive Variability in NF1 and TSC Monozygotic Twins (COVANTT)

Tuberous Sclerosis Complex | Neurofibromatosis Type I

Netherlands
Actelion

Completed

Bosentan in Systemic Sclerosis (HOME)

Systemic Sclerosis | Digital Ulcers

Netherlands
Delta Crystallon BV

Completed

Safety and Dose-finding Study of DC-TAB in Healthy Subjects

Multiple Sclerosis

Netherlands
University Medical Center Groningen

Not yet recruiting

TENS in Persons With MS

Multiple Sclerosis

Netherlands
Sanofi
Denali Therapeutics Inc.

Terminated

Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States, Netherlands
Hasselt University

Unknown

Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients

Multiple Sclerosis | Paralytic Stroke

Belgium, Netherlands
University Medical Center Groningen

Recruiting

Improving Social Cognition and Social Behaviour in Various Brain Disorders (T-ScEmo4ALL)

Stroke | Multiple Sclerosis | Brain Tumor

Netherlands
Amsterdam UMC, location VUmc
Netherlands Brain Foundation

Recruiting

Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body (HersenFIT)

Multiple Sclerosis | Parkinson Disease

Netherlands
Wellspect HealthCare

Terminated

Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction

Multiple Sclerosis | Bladder Dysfunction

Belgium, Netherlands, Germany, United Kingdom
Haukeland University Hospital

Recruiting

Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS) (RAM-MS)

Multiple Sclerosis

Norway, Sweden, Denmark, Netherlands
Orion Corporation, Orion Pharma

Completed

Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Ireland, Netherlands, United Kingdom, Germany
Eli Lilly and Company
BioMS Technology Corp.

Completed

A Study for Patients With Secondary Progressive Multiple Sclerosis (MAESTRO-01)

Secondary Progressive Multiple Sclerosis

Canada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
Amsterdam UMC, location VUmc
Innovatiefonds Zorgverzekeraars; Stichting MS Research; Stichting Treatmeds

Enrolling by invitation

Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis (SUPERNEXT)

Relapsing Remitting Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
GGZ inGeest; Parnassia Bavo Groep

Terminated

Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy

Multiple Sclerosis | Idiopathic Parkinson's Disease | Elderly Post Electric Convulsive Therapy

Netherlands
Genzyme, a Sanofi Company

Completed

Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA (EMERALD)

Relapsing-remitting Multiple Sclerosis

Belgium, Spain, France, Netherlands

Clinical Trials on Necrotizing Scleritis in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations